(1634) Respiratory Syncytial Virus-Associated Health Care Utilization in the Pivotal Phase 3 Trial RSV Vaccine Efficacy Study In Older Adults Immunized Against RSV Disease (RENOIR)

Professor of Medicine
University of Rochester
Rochester, NY, United States

Director, Clinician Medical Monitor
Vaccine Research and Development, Pfizer, USA
Raleigh, North Carolina, United States

Director Vaccines Research
Pfizer
Pearl RIver, New York, United States

Senior Director
Pfizer
Collegeville, Pennsylvania, United States

Hospital Militar Central de Buenos Aires
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Huisartsenpraktijk Radesingel
Radesingel, Groningen, Netherlands

Principal Investigator
Emmed Research
Pretoria, Gauteng, South Africa

Diablo Clinical Research
Walnut Creek, California, United States

Medical Corporation Asbo, Tokyo Asbo Clinic
Kyobashi Chuo-ku, Tokyo, Japan

Terveystalo Jyväskylä
Jyväskyla, Keski-Suomi, Finland

Associate Director
Pfizer
Pearly River, New York, United States

Pfizer, Vaccine Research and Development
Hurley, England, United Kingdom

Clinical Scientist (Senior Manager)
Pfizer
Pearl River, New York, United States

Associate Director
Pfizer, Inc.
Pearl River, New York, United States

Associate Medical Director
3. Pfizer, Inc., Vaccine Research & Development
Pearl River, New York, United States

Director
Pfizer
Pearl River, New York, United States

Senior Director
Pfizer
Pearl River, New York, United States

SVP & CSO
Pfizer
New York, New York, United States

Vice President, Viral Vaccines
Pfizer
Pearl River, New York, United States

SVP
Pfizer
Pearl River, New York, United States

Vice President
Pfizer
Pearl River, New York, United States

Dr.
Pfizer
Pearl River, New York, United States